Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

Trump’s $9 billion clawback passes first Senate test, while more hurdles await

by admin July 16, 2025
July 16, 2025
Trump’s $9 billion clawback passes first Senate test, while more hurdles await

President Donald Trump’s clawback of billions in funding for foreign aid and public broadcasting narrowly passed through its first hurdle in the Senate, but it still faces a rocky road ahead with dissent among the Senate GOP ranks.

Senate GOP leaders hoped that an agreement to carve out $400 million in global HIV and AIDS prevention funding will get some of the holdouts on board. However, doing so shrank the expected cuts from $9.4 billion to $9 billion.

But a trio of Senate Republicans joined with all Senate Democrats to vote against advancing the bill from the Senate Appropriations Committee, which required Vice President JD Vance to cast the deciding vote. 

Trump’s rescissions package would yank bank congressionally approved funding for foreign aid programs and public broadcasting. But some Senate Republicans have sounded the alarm and want changes made to the bill before it reaches the finish line.

The bill that advanced out of committee Tuesday includes just shy of $8 billion in cuts from the U.S. Agency for International Development (USAID), and over $1 billion from the Corporation for Public Broadcasting (CPB), the government-backed funding arm for NPR and PBS.

Republicans’ successful test vote comes after huddling with Office of Management and Budget Director Russ Vought, who worked to shore up support and apply pressure from the White House to get the ball rolling on the bill.

‘We’re fine with adjustments,’ Vought said. ‘This is still a great package, $9 billion, [it’s] substantially the same package, and the Senate has to work its will.’

While concerns were still raised about other aspects of the spending cuts package during the closed-door meeting, Senate Majority Leader John Thune, R-S.D., believed that carving out the cuts to Bush-era President’s Emergency Plan for AIDS Relief (PEPFAR) helped ease concerns among lawmakers.

But the changes didn’t sway all Senate Republicans. Sen. Lisa Murkowski, R-Alaska, bluntly said ‘no’ when asked if the PEPFAR carveout helped gain her support and argued, ‘I’d like to do some legislating.’ 

‘What a crazy thing, what a crazy thing,’ she said. ‘What have we been doing around here? We did a reconciliation bill. We’re doing a rescissions bill. We’re doing nominations. Nominations are important, but let’s, like, legislate.’

And Sen. Susan Collins, R-Maine, said she liked the changes but ultimately decided to vote against advancing the bill through its first hurdle.

Sen. Mitch McConnell, R-Ky., also joined in to vote against the bill. Fox News Digital reached out to his office for a statement on his decision to vote against the package. 

It now moves to yet another procedural vote, which, if successful, will open up 10 hours of total debate time on the bill and eventually set the stage for a vote-a-rama, where lawmakers on either side of the aisle can offer an unlimited number of amendments to the package.

But, House Speaker Mike Johnson, R-La., made clear that he would prefer the Senate not make any changes to the bill.

However, that request already fell on deaf ears — as it did during the budget reconciliation process that unfolded in the upper chamber last month.

Those demands already have fiscal hawks in the House grumbling, but like the budget reconciliation process before it, an amended rescissions package will likely glide through the House GOP and onto Trump’s desk. 

This post appeared first on FOX NEWS

previous post
Athena Gold Completes Till Survey At Laird Lake Project In Ontario’s Red Lake Gold Camp
next post
Huckabee demands Israel ‘aggressively investigate’ murder of Palestinian-American killed in ‘terrorist act’

Related Posts

Trump announces Dan Bongino will be deputy director...

February 24, 2025

US ends terrorist designation of Syrian militant leaders

July 8, 2025

Republicans ready late-night session on Trump’s ‘big, beautiful...

May 19, 2025

Waltz doubles down on Hegseth praise amid ongoing...

April 28, 2025

Trump inauguration performer Gavin DeGraw salutes ‘businessman running...

January 23, 2025

How Trump-blocking judges managed to get past Senate...

March 30, 2025

Trump tariff spike fuels new House bill to...

April 11, 2025

Election Day in Wisconsin, Florida: What to watch...

April 2, 2025

Trump says ceasefire should be canceled if hostages...

February 11, 2025

Trump to subject all contracts, grants through rigorous...

February 27, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 5

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved